Literature DB >> 8886576

Erythropoietin stimulates proliferation of rat-cultured gastric mucosal cells.

A Okada1, Y Kinoshita, T Maekawa, M S Hassan, C Kawanami, M Asahara, Y Matsushima, K Kishi, H Nakata, Y Naribayashi, T Chiba.   

Abstract

Most anemic patients with chronic renal failure have gastric mucosal lesions. However, these gastric lesions are often improved after the administration of recombinant human erythropoietin (rHuEPO). We have used the rat gastric mucosal cell line RGM-1, to examine the possibility that rHuEPO might directly stimulate the growth of gastric mucosal cells in vitro. Our results show that rHuEPO dose-dependently increased [3H]thymidine incorporation into RGM-1 cells and their expression of c-myc gene. In addition, 125I-rHuEPO specifically bound to RGM-1 cells, and moreover, erythropoietin receptor gene expression was detected by RT-PCR. We conclude that rHuEPO has a direct growth-promoting effect on RGM-1 cells, suggesting possible usefulness of rHuEPO administration for the treatment of gastric mucosal damage in patients with chronic renal failure.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8886576     DOI: 10.1159/000201353

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  7 in total

1.  Erythropoietin acts as a trophic factor in neonatal rat intestine.

Authors:  S E Juul; D J Ledbetter; A E Joyce; C Dame; R D Christensen; Y Zhao; V DeMarco
Journal:  Gut       Date:  2001-08       Impact factor: 23.059

2.  Clinical Outcomes Related to the Gastrointestinal Trophic Effects of Erythropoietin in Preterm Neonates: A Systematic Review and Meta-Analysis.

Authors:  Anitha Ananthan; Haribalakrishna Balasubramanian; Shripada Rao; Sanjay Patole
Journal:  Adv Nutr       Date:  2018-05-01       Impact factor: 8.701

3.  Erythropoietin-induced proliferation of gastric mucosal cells.

Authors:  Kazuro Itoh; Yoshio Sawasaki; Kyoko Takeuchi; Shingo Kato; Nobuhiro Imai; Yoichiro Kato; Noriyuki Shibata; Makio Kobayashi; Yoshiyuki Moriguchi; Masato Higuchi; Fumio Ishihata; Yushi Sudoh; Soichiro Miura
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

Review 4.  Erythropoietin in heart and vessels: focus on transcription and signalling pathways.

Authors:  Francesca Marzo; Alberto Lavorgna; Giulio Coluzzi; Eleonora Santucci; Federica Tarantino; Teresa Rio; Elena Conti; Camillo Autore; Luciano Agati; Felicita Andreotti
Journal:  J Thromb Thrombolysis       Date:  2008-03-13       Impact factor: 2.300

5.  EPO-R expression patterns in resected gastric adenocarcinoma followed by adjuvant chemoradiation treatment.

Authors:  Maria Sereno; Javier De Castro; Cristóbal Belda-Iniesta; Miguel Angel Garcia-Cabezas; Paloma Cejas; Enrique Casado; Jorge Barriuso; Jaime Feliu; Javier Larrauri
Journal:  Pathol Oncol Res       Date:  2008-11-11       Impact factor: 3.201

6.  Comparison of oral recombinant erythropoietin and subcutaneous recombinant erythropoietin in prevention of anemia of prematurity.

Authors:  R Saeidi; A Banihashem; M Hammoud; M Gholami
Journal:  Iran Red Crescent Med J       Date:  2012-03-01       Impact factor: 0.611

Review 7.  Science review: recombinant human erythropoietin in critical illness: a role beyond anemia?

Authors:  Thomas Coleman; Michael Brines
Journal:  Crit Care       Date:  2004-06-16       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.